Immunocore Holdings’ $402.5 Million Convertible Notes Offering

Davis Polk & Wardwell advised the several initial purchasers on the offering.Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now